ALPHACENTRIC ADVISORS LLC
Q2 2024 Form 13-F
SAN JUAN, PUERTO RICO
CIK 0001913464
· CRD 170679
· SEC-registered investment adviser
$135.8M Reported Value Total
ALPHACENTRIC ADVISORS LLC reports 7 total accounts under management (AUM). There are 7 discretionary accounts valued at $728,151,543, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Source: Form ADV filed 2026-06-02
Reported value
$135.8M
Quarter over quarter
-5.5%
Holdings
217
Top-10 concentration
25.5%
Key People
Form ADV owners & control persons
David Scott Miller
MEMBER
Jerry John Szilagyi
MANAGING MEMBER
Michael Thomas Schoonover
MEMBER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2024 13F record
Q2 2024 13F filing summary
| Period of report | June 30, 2024 |
|---|---|
| Filed | July 25, 2024 |
| Form | 13F-HR |
| Reported value | $135.8M |
| Positions | 217 |
| Change in reported value | -18.1% |
| New positions | 35 |
| Exited positions | 46 |
| Position turnover | 30.8% |
| Top-10 concentration | 25.5% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 3, 2026
|
245 | $112.6M |
|
Q2 2026 13F
Filed Jul 24, 2026
|
259 | $118.0M |
|
Q1 2026 13F
Filed May 7, 2026
|
252 | $100.1M |
|
Q4 2025 13F
Filed Feb 12, 2026
|
249 | $100.3M |
|
Q4 2024 13F
Filed Jan 31, 2025
|
209 | $100.2M |
|
Q3 2024 13F
Filed Oct 30, 2024
|
230 | $134.5M |
|
Q2 2024 13F
Filed Jul 25, 2024
|
217 | $135.8M |
|
Q1 2024 13F
Filed Apr 24, 2024
|
228 | $165.8M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
216 | $149.0M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
234 | $176.3M |
|
Q2 2023 13F
Filed Aug 8, 2023
|
231 | $180.2M |
|
Q1 2023 13F
Filed May 12, 2023
|
209 | $144.9M |
|
Q4 2022 13F
Filed Feb 7, 2023
|
165 | $101.2M |
|
Q3 2022 13F
Filed Nov 8, 2022
|
184 | $97.4M |
|
Q4 2021 13F
Filed Feb 25, 2022
|
220 | $343.1M |
6 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | UTHR UNITED THERAPEUTICS CORP DEL | $4.6M | 3.4% |
| 2 | BCRX BIOCRYST PHARMACEUTICALS INC | $4.2M | 3.07% |
| 3 | RITM RITHM CAPITAL CORP | $4.2M | 3.06% |
| 4 | PFE PFIZER INC | $3.9M | 2.88% |
| 5 | HRMY HARMONY BIOSCIENCES HLDGS IN | $3.7M | 2.71% |
| 6 | PCRX PACIRA BIOSCIENCES INC | $3.4M | 2.48% |
| 7 | ARGX ARGENX SE | $3.1M | 2.3% |
| 8 | LKFT GALAPAGOS NV | $2.7M | 1.98% |
| 9 | MTG MGIC INVT CORP WIS | $2.5M | 1.82% |
| 10 | EFC ELLINGTON FINANCIAL INC | $2.4M | 1.79% |
| 11 | MIRM MIRUM PHARMACEUTICALS INC | $2.2M | 1.61% |
| 12 | DX DYNEX CAP INC | $2.2M | 1.6% |
| 13 | ONC BEIGENE LTD | $2.1M | 1.58% |
| 14 | QURE UNIQURE NV | $2.1M | 1.52% |
| 15 | FOLD AMICUS THERAPEUTICS INC | $2.0M | 1.48% |
| 16 | DCGO DOCGO INC | $2.0M | 1.48% |
| 17 | RWT REDWOOD TRUST INC | $1.9M | 1.38% |
| 18 | MFA MFA FINL INC | $1.8M | 1.31% |
| 19 | CLDX CELLDEX THERAPEUTICS INC NEW | $1.8M | 1.29% |
| 20 | CERE CEREVEL THERAPEUTICS HLDNG I | $1.7M | 1.28% |
Values as reported on the Q2 2024 Form 13F. Every position is in the holdings table below.